Revenue was 35,999 million yen (4.5% YoY increase), operating income was 798 million yen (54.0% YoY increase), and net income attributable to owners of parent was 648 million yen (51.2% YoY increase). The outlook for the next fiscal year forecasts lower revenue and profit. Dividends are planned at 140 yen (year-end) and 110 yen for the next fiscal year. By segment, Industry is the core contributor while Medical shows growth.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7446","jir_company_name":"Tohoku Chemical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7446-20261113-01.pdf","jir_short_summary":"Revenue was 35,999 million yen (4.5% YoY increase), operating income was 798 million yen (54.0% YoY increase), and net income attributable to owners of parent was 648 million yen (51.2% YoY increase). The outlook for the next fiscal year forecasts lower revenue and profit. Dividends are planned at 140 yen (year-end) and 110 yen for the next fiscal year. By segment, Industry is the core contributor while Medical shows growth.","jir_summary":"### Overview of Performance\nFor the fiscal year under review, revenue was in the high 35,900 million yen range, representing a 4.5% increase year-on-year. Operating income rose significantly to 79.8 million yen, ordinary income was approximately 90.8 million yen, and net income attributable to owners of parent was approximately 648 million yen, marking substantial profit growth. By segment, Industry contributed the most, and Medical also posted higher revenue and profits. Conversely, Academia & Life Sciences experienced declines in both revenue and profit.\n\n### Outlook and Dividends\nFor the fiscal year ending September 2027, revenue and profits are forecast to decline, based on assumptions including rising energy and resource costs. Dividends are planned at 140 yen at fiscal year-end, and 110 yen for the next fiscal year, maintaining a policy of stable dividends. The company also states its intention to utilize retained earnings to strengthen the financial structure.","jir_financial_highlights":"Revenue: 35,999,571 (YoY 4.5% increase)\nOperating Income: 798,310 (YoY 54.0% increase)\nOrdinary Income: 908,307 (YoY 52.6% increase)\nNet Income Attributable to Owners of Parent: 648,130 (YoY 51.2% increase)\nNet Income Per Share: 719.41 (Unknown)","jir_category":"","jir_hashtags":"#TohokuChemical, #FinancialResults, #BusinessSegments, #DividendPolicy","jir_key_figures":"Revenue: 35,999,571 thousand yen (YoY 4.5% increase)\nOperating Income: 798,310 thousand yen (YoY 54.0% increase)\nNet Income Attributable to Owners of Parent: 648,130 thousand yen (YoY 51.2% increase)","jir_meta_title":"Tohoku Chemical Co., Ltd. FY2026 September Financial Results | Revenue 35,999 million yen, Increased Revenue and Profit","jir_meta_description":"Key points of Tohoku Chemical Co., Ltd.'s FY2026 September financial results. Revenue up 4.5%; operating income and net income significantly higher. Next fiscal year outlook forecasts lower revenue and profit. Dividends planned at 140 yen (year-end) and 110 yen next year. Industry segment led performance.","jir_og_title":"Tohoku Chemical Co., Ltd. Earnings Release: Revenue 35,999 million yen, Profit Increase","jir_og_description":"Tohoku Chemical Co., Ltd.'s FY2026 September results show revenue and profit growth. Dividends planned at 140 yen (year-end) and 110 yen next fiscal year. Outlook forecasts lower revenue and profit.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025\/9\\\",\\\"2026\/9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[344442.625,35999.571],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025\/9\\\",\\\"2026\/9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[518.395,798.310],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]}}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025\/9\\\",\\\"2026\/9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[428.799,648.130],\\\"borderColor\\\":\\\"#3cba9f\\\",\\\"fill\\\":false}]}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue by Segment\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Industry\\\",\\\"Medical\\\",\\\"Academia & Life Sciences\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[189.283,148. \u2022,,\\\"}]}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Margin and Ordinary Income Margin Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025\/9\\\",\\\"2026\/9\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[1.50,2.22],\\\"borderColor\\\":\\\"#e8c3a0\\\",\\\"fill\\\":false}]}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Comparison of Forecast and Actual\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":[]}\"}]","ir_related_company":60511,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-153284","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n